Prostate Cancer Screening and Risk of Litigation: Caught between Scylla and Charybdis

Abstract

No AccessJournal of UrologyEditorial1 Jun 2014Prostate Cancer Screening and Risk of Litigation: Caught between Scylla and Charybdis Michael H. Hsieh and Max V. Meng Michael H. HsiehMichael H. Hsieh More articles by this author and Max V. MengMax V. Meng More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2014.03.085AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Prostate Cancer Screening and Risk of Litigation: Caught between Scylla and Charybdis." The Journal of Urology, 191(6), pp. 1648–1649 References 1 U.S. Preventive Services Task Force: Screening for Prostate Cancer: Current Recommendation, May 2012. Available at www.uspreventiveservicestaskforce.org/prostatecancerscreening.htm. Accessed February 2014. Google Scholar 2 : The impact of recent screening recommendations on prostate cancer screening in a large health care system. J Urol2014; 191: 1737. Link, Google Scholar 3 : Primary care providers’ perspectives on discontinuing prostate cancer screening. Cancer2012; 118: 5518. Google Scholar 4 : A piece of my mind. Winners and losers. JAMA2004; 291: 15. Google Scholar 5 : Influencing factors leading to malpractice litigation in radical prostatectomy. J Urol2014; 191: 1770. Link, Google Scholar 6 : The Odyssey, translated by R Fitzgerald. New York: Alfred A. Knopf1992. Google Scholar 7 : Urinary PCA3 as a predictor of prostate cancer in a cohort of 3,073 men undergoing initial prostate biopsy. J Urol2014; 191: 1743. Link, Google Scholar 8 : Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay. Eur Urol2013; 63: 201. Google Scholar 9 : Prostate health index (Phi) and prostate cancer antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml. PLoS One2013; 8: e67687. Google Scholar © 2014 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byMiller A, Yates J, Epstein M, Fantasia J, Frendl D, Afiadata A, Sokoloff M and Luckmann R (2018) Impact of 2012 USPSTF Screening PSA Guideline Statement: Changes in Primary Care Provider Practice Patterns and AttitudesUrology Practice, VOL. 4, NO. 2, (126-131), Online publication date: 1-Mar-2017. Volume 191Issue 6June 2014Page: 1648-1649 Advertisement Copyright & Permissions© 2014 by American Urological Association Education and Research, Inc.MetricsAuthor Information Michael H. Hsieh More articles by this author Max V. Meng More articles by this author Expand All Advertisement PDF downloadLoading ...